Sheaff Brock Investment Advisors, LLC Acadia Pharmaceuticals Inc Transaction History

Sheaff Brock Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$23.32 - $28.12 $2.37 Million - $2.85 Million	-101,500 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$16.17 - $27.38 $24,255 - $41,070	1,500 Added 1.5%	101,500 $2.73 Million
Q4 2018 Jan 28, 2019	BUY	$14.32 - $22.92 $393,800 - $630,300	27,500 Added 37.93%	100,000 $1.62 Million
Q3 2018 Nov 09, 2018	BUY	$13.03 - $21.81 $293,175 - $490,725	22,500 Added 45.0%	72,500 $1.51 Million
Q3 2017 Nov 13, 2017	SELL	$29.49 - $38.37 $29,490 - $38,370	-1,000 Reduced 1.96%	50,000 $1.88 Million
Q2 2017 Aug 09, 2017	BUY	N/A	51,000	51,000 $1.42 Million

326

166M

855K

350K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.32B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.